Karolinska co-founds pharma company with BioChromix and formalises Uminova relationship
This article was originally published in Scrip
Executive Summary
The Swedish investment company Karolinska Development and BioChromix, a life sciences company also based in Sweden, have created a new company called BioChromix Pharma to develop novel Alzheimer's disease treatments.